Oxidative stress and cancer pain

Canadian Journal of Physiology and Pharmacology

Volumn 91, Issue 1, 2013, Pages 31-37

  Ungard, Robert G ^a   Seidlitz, Eric P ^a   Singh, Gurmit ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

Bone; Cancer; Glutamate; Oxidative stress; Pain; Sulfasalazine; System x C

Indexed keywords

CYSTINE; GLUTAMATE RECEPTOR 1; GLUTAMATE RECEPTOR 5; GLUTAMIC ACID; IONOTROPIC RECEPTOR; MELOXICAM; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; REACTIVE OXYGEN METABOLITE; SALAZOSULFAPYRIDINE;

BONE CELL; BONE PAIN; BREAKTHROUGH PAIN; BREAST CANCER; CANCER CELL; CANCER PAIN; CANCER PATIENT; CELL DEATH; GLIOMA CELL; HUMAN; IMMUNE RESPONSE; IN VITRO STUDY; IN VIVO STUDY; METASTASIS; NEUROPATHIC PAIN; NOCICEPTION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

BONE AND BONES; BONE NEOPLASMS; BREAST NEOPLASMS; CYSTEINE; FEMALE; GLUTAMIC ACID; HUMANS; NOCICEPTIVE PAIN; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES;

EID: 84873589271     PISSN: 00084212     EISSN: 12057541     Source Type: Journal    
DOI: 10.1139/cjpp-2012-0298     Document Type: Review

References (95)

1. Arcella, A., Carpinelli, G., Battaglia, G., D'Onofrio, M., Santoro, F., Ngomba, R.T., et al. 2005. Pharmacological blockade of group II metabotropic glutamate receptors reduces the growth of glioma cells in vivo. Neuro. Oncol. 7(3): 236-245. doi:10.1215/S1152851704000961. PMID:16053698.
2. Balendiran, G.K., Dabur, R., and Fraser, D. 2004. The role of glutathione in cancer. Cell Biochem. Funct. 22(6): 343-352. doi:10.1002/cbf.1149. PMID: 15386533.
3. Banjac, A., Perisic, T., Sato, H., Seiler, A., Bannai, S., Weiss, N., et al. 2008. The cystine/cysteine cycle: a redox cycle regulating susceptibility versus resistance to cell death. Oncogene, 27(11): 1618-1628. doi:10.1038/sj.onc.1210796. PMID:17828297.
4. Bannai, S., and Ishii, T. 1988. A novel function of glutamine in cell culture: utilization of glutamine for the uptake of cystine in human fibroblasts. J. Cell. Physiol. 137(2): 360-366. doi:10.1002/jcp.1041370221. PMID:2903864.
5. Bannai, S., and Kitamura, E. 1980. Transport interaction of L-cystine and L-glutamate in human diploid fibroblasts in culture. J. Biol. Chem. 255(6): 2372-2376. PMID:7358676.
6. Benyamin, R., Trescot, A.M., Datta, S., Buenaventura, R., Adlaka, R., Sehgal, N., et al. 2008. Opioid complications and side effects. Pain Physician, 11(2 Suppl.): S105-S120.
7. Bleakman, D., Alt, A., and Nisenbaum, E.S. 2006. Glutamate receptors and pain. Semin. Cell Dev. Biol. 17(5): 592-604. doi:10.1016/j.semcdb.2006.10.008. PMID: 17110139.
8. Bloom, A.P., Jimenez-Andrade, J.M., Taylor, R.N., Castaneda-Corral, G., Kaczmarska, M.J., Freeman, K.T., et al. 2011. Breast cancer-induced bone remodeling, skeletal pain, and sprouting of sensory nerve fibers. J. Pain, 12(6): 698-711. doi:10.1016/j.jpain.2010.12.016. PMID:21497141.
9. Brater, D.C. 1999. Effects of nonsteroidal anti-inflammatory drugs on renal function: focus on cyclooxygenase-2-selective inhibition. Am. J. Med. 107(6A): 65S-70S; discussion 70S-71S. doi:10.1016/S0002-9343(99)00369-1. PMID: 10628595.
10. Buckingham, S.C., Campbell, S.L., Haas, B.R., Montana, V., Robel, S., Ogunrinu, T., et al. 2011. Glutamate release by primary brain tumors induces epileptic activity. Nat. Med. 17(10): 1269-1274. doi:doi:10.1038/nm.2453. PMID: PMID:21909104.
11. Cairns, B.E., Svensson, P., Wang, K., Castrillon, E., Hupfeld, S., Sessle, B. J.et al. 2006. Ketamine attenuates glutamate-induced mechanical sensitization of the masseter muscle in human males. Exp. Brain Res. 169(4): 467-472. doi: 10.1007/s00221-005-0158-z. PMID:16292641.
12. Caraceni, A., and Portenoy, R.K. 1999. An international survey of cancer pain characteristics and syndromes. IASP Task Force on Cancer Pain. International Association for the Study of Pain. Pain, 82: 263-274. doi:10.1016/S03043959(99)00073-1. PMID:10488677.
13. Caraceni, A., Martini, C., Zecca, E., Portenoy, R.K., Ashby, M.A., Hawson, G., et al. 2004. Breakthrough pain characteristics and syndromes in patients with cancer pain. An international survey. Palliat. Med. 18(3): 177-183. doi:10.1191/ 0269216304pm890oa. PMID:15198130.
14. Carlton, S.M., and Coggeshall, R.E. 1999. Inflammation-induced changes in peripheral glutamate receptor populations. Brain Res. 820(1-2): 63-70. doi:10. 1016/S0006-8993(98)01328-6. PMID:10023031.
15. Carlton, S.M., Hargett, G.L., and Coggeshall, R.E. 1995. Localization and activation of glutamate receptors in unmyelinated axons of rat glabrous skin. Neurosci. Lett. 197(1): 25-28. doi:10.1016/0304-3940(95)11889-5. PMID: 8545047.
16. Chillarón, J., Roca, R., Valencia, A., Zorzano, A., and Palacin, M. 2001. Heteromeric amino acid transporters: biochemistry, genetics, and physiology. Am. J. Physiol. Renal Physiol. 281(6): F995-F1018. PMID:11704550.
17. Cho, Y., and Bannai, S. 1990. Uptake of glutamate and cysteine in C-6 glioma cells and in cultured astrocytes. J. Neurochem. 55(6): 2091-2097. doi:10.1111/j.14714159.1990.tb05800.x. PMID:1977889.
18. Chung, W.J., Lyons, S.A., Nelson, G.M., Hamza, H., Gladson, C.L., Gillespie, G.Y., et al. 2005. Inhibition of cystine uptake disrupts the growth of primary brain tumors. J. Neurosci. 25(31): 7101-7110. doi:10.1523/JNEUROSCI.5258-04.2005. PMID:16079392.
19. Coleman, R.E. 2006. Clinical features of metastatic bone disease and risk of skeletal morbidity. Clin. Cancer Res. 12(20): 6243s-6249s. 10.1158/1078-0432.CCR-06-0931.
20. Coleman, R.E., and Rubens, R.D. 1987. The clinical course of bone metastases from breast cancer. Br. J. Cancer, 55(1): 61-66. doi:10.1038/bjc.1987.13. PMID: 3814476.
21. Cowan, R.W., Seidlitz, E.P., and Singh, G. 2012. Glutamate signaling in healthy and diseased bone. Front. Endocrinol. (Lausanne), 3: 89. doi:10.3389/fendo.2012.00089. PMID:22833735.
22. De Ciantis, P., Yashpal, K., Henry, J.L., and Singh, G. 2010. Characterization of a rat model of metastatic prostate cancer bone pain. J. Pain Res. 3: 213-221. PMID:21197325.
23. Dingledine, R., Borges, K., Bowie, D., and Traynelis, S.F. 1999. The glutamate receptor ion channels. Pharmacol. Rev. 51(1): 7-61. PMID:10049997.
24. Doxsee, D.W., Gout, P.W., Kurita, T., Lo, M., Buckley, A.R., Wang, Y., et al. 2007. Sulfasalazine-induced cystine starvation: potential use for prostate cancer therapy. Prostate, 67(2): 162-171. doi:10.1002/pros.20508. PMID:17075799.
25. Fundytus, M.E. 2001. Glutamate receptors and nociception: implications for the drug treatment of pain. CNS Drugs, 15(1): 29-58. doi:10.2165/00023210200115010-00004. PMID:11465012.
26. Gatenby, R.A., Gawlinski, E.T., Gmitro, A.F., Kaylor, B., and Gillies, R.J. 2006. Acid-mediated tumor invasion: a multidisciplinary study. Cancer Res. 66(10): 5216-5223. doi:10.1158/0008-5472.CAN-05-4193. PMID:16707446.
27. Giacometti, T. 1979. Free and bound glutamate in natural products. In Glutamic acid: advances in biochemistry and physiology. Edited by L. Filer, S. Garattini, M. Kare, W. Reynolds, and R. Wurtman New York: Raven Press. pp. 25-34.
28. Gout, P.W., Buckley, A.R., Simms, C.R., and Bruchovsky, N. 2001. Sulfasalazine, a potent suppressor of lymphoma growth by inhibition of the x(c) cystine transporter: a new action for an old drug. Leukemia, 15(10): 1633-1640. doi: 10.1038/sj.leu.2402238. PMID:11587223.
29. Guan, J., Lo, M., Dockery, P., Mahon, S., Karp, C.M., Buckley, A.R., et al. 2009. The xccystine/glutamate antiporter as a potential therapeutic target for small-cell lung cancer: use of sulfasalazine. Cancer Chemother. Pharmacol. 64(3): 463-472. doi:10.1007/s00280-008-0894-4. PMID:19104813.
30. Halvorson, K.G., Sevcik, M.A., Ghilardi, J.R., Rosol, T.J., and Mantyh, P.W. 2006. Similarities and differences in tumor growth, skeletal remodeling and pain in an osteolytic and osteoblastic model of bone cancer. Clin. J. Pain, 22(7): 587-600. doi:10.1097/01.ajp.0000210902.67849.e6. PMID:16926574.
31. Harrington, J.F., Messier, A.A., Bereiter, D., Barnes, B., and Epstein, M.H. 2000. Herniated lumbar disc material as a source of free glutamate available to affect pain signals through the dorsal root ganglion. Spine, 25: 929-936. doi:10.1097/00007632-200004150-00006. PMID:10767804.
32. Honore, P., Rogers, S.D., Schwei, M.J., Salak-Johnson, J.L., Luger, N.M., Sabino, M.C., et al. 2000. Murine models of inflammatory, neuropathic and cancer pain each generates a unique set of neurochemical changes in the spinal cord and sensory neurons. Neuroscience, 98(3): 585-598. doi:10.1016/ S0306-4522(00)00110-X. PMID:10869852.
33. Huang, Y., Dai, Z., Barbacioru, C., and Sadee, W. 2005. Cystine-glutamate transporter SLC7A11 in cancer chemosensitivity and chemoresistance. Cancer Res. 65(16): 7446-7454. doi:10.1158/0008-5472.CAN-04-4267. PMID:16103098.
34. Hwang, C., Sinskey, A.J., and Lodish, H.F. 1992. Oxidized redox state of glutathione in the endoplasmic reticulum. Science, 257(5076): 1496-1502. doi:10.1126/science.1523409. PMID:1523409.
35. IARC. 2010. Globocan 2008. Available from http://globocan.iarc.fr/factsheets/populations/factsheet.asp?uno=900.
36. Ishii, T., Sugita, Y., and Bannai, S. 1987. Regulation of glutathione levels in mouse spleen lymphocytes by transport of cysteine. J. Cell. Physiol. 133(2): 330-336. doi:10.1002/jcp.1041330217. PMID:3680392.
37. Jang, J.H., Kim, D.W., Sang Nam, T., Se Paik, K., and Leem, J.W. 2004. Peripheral glutamate receptors contribute to mechanical hyperalgesia in a neuropathic painmodeloftherat. Neuroscience,128(1):169-176. doi:10.1016/j.neuroscience. 2004.06.040. PMID:15450364.
38. Jimenez-Andrade, J.M., Mantyh, W.G., Bloom, A.P., Ferng, A.S., Geffre, C.P., and Mantyh, P.W. 2010. Bone cancer pain. Ann. N.Y. Acad. Sci. 1198: 173-181. doi:10.1111/j.1749-6632.2009.05429.x. PMID:20536932.
39. Jimenez-Andrade, J.M., Ghilardi, J.R., Castaneda-Corral, G., Kuskowski, M.A., and Mantyh, P.W. 2011. Preventive or late administration of anti-NGF therapy attenuates tumor-induced nerve sprouting, neuroma formation, and cancer pain. Pain, 152(11): 2564-2574. doi:10.1016/j.pain.2011.07.020. PMID:21907491.
40. Kaleeba, J.A., and Berger, E.A. 2006. Kaposi's sarcoma-associated herpesvirus fusion-entry receptor: cystine transporter xCT. Science, 311(5769): 1921-1924. 10.1126/science.1120878. 16574866.
41. Kato, S., Negishi, K., Mawatari, K., and Kuo, C.H. 1992. A mechanism for glutamate toxicity in the C6 glioma cells involving inhibition of cystine uptake leading to glutathione depletion. Neuroscience, 48(4): 903-914. doi:10.1016/ 0306-4522(92)90278-A. PMID:1352866.
42. Kau, K.S., Madayag, A., Mantsch, J.R., Grier, M.D., Abdulhameed, O., and Baker, D.A. 2008. Blunted cystine-glutamate antiporter function in the nucleus accumbens promotes cocaine-induced drug seeking. Neuroscience, 155(2): 530-537. doi:10.1016/j.neuroscience.2008.06.010. PMID:18601982.
43. Kim, J.Y., Kanai, Y., Chairoungdua, A., Cha, S.H., Matsuo, H., Kim, D. K. et al. 2001. Human cystine/glutamate transporter: cDNA cloning and upregulation by oxidative stress in glioma cells. Biochim. Biophys. Acta, 1512(2): 335-344. doi:10.1016/S0005-2736(01)00338-8. PMID:11406111.
44. Kroemer, G., and Pouyssegur, J. 2008. Tumor cell metabolism: cancer's Achilles' heel. Cancer Cell, 13(6): 472-482. doi:10.1016/j.ccr.2008.05.005. PMID: 18538731.
45. Lo, M., Ling, V., Wang, Y.Z., and Gout, P.W. 2008. The xccystine/glutamate antiporter: a mediator of pancreatic cancer growth with a role in drug resistance. Br. J. Cancer, 99(3): 464-472. doi:10.1038/sj.bjc.6604485. PMID: 18648370.
46. Loeser, J.D., and Treede, R.D. 2008. The Kyoto protocol of IASP Basic Pain Terminology. Pain, 137(3): 473-477. doi:10.1016/j.pain.2008.04.025. PMID:18583048.
47. Mach, D.B., Rogers, S.D., Sabino, M.C., Luger, N.M., Schwei, M.J., Pomonis, J.D., et al. 2002. Origins of skeletal pain: sensory and sympathetic innervation of the mouse femur. Neuroscience, 113(1): 155-166. doi:10.1016/S0306-4522(02) 00165-3. PMID:12123694.
48. Mantyh, W.G., Jimenez-Andrade, J.M., Stake, J.I., Bloom, A.P., Kaczmarska, M.J., Taylor, R.N., et al. 2010. Blockade of nerve sprouting and neuroma formation markedly attenuates the development of late stage cancer pain. Neuroscience, 171(2): 588-598. doi:10.1016/j.neuroscience.2010.08.056. PMID: 20851743.
49. Massie, A., Schallier, A., Mertens, B., Vermoesen, K., Bannai, S., Sato, H., et al. 2008. Time-dependent changes in striatal xCT protein expression in hemi-Parkinson rats. Neuroreport, 19(16): 1589-1592. doi:10.1097/WNR. 0b013e328312181c. PMID:18806690.
50. McNearney, T., Speegle, D., Lawand, N., Lisse, J., and Westlund, K.N. 2000. Excitatory amino acid profiles of synovial fluid from patients with arthritis. J. Rheumatol. 27(3): 739-745. PMID:10743819.
51. Mercadante, S. 1997. Malignant bone pain: pathophysiology and treatment. Pain, 69(1-2): 1-18. doi:10.1016/S0304-3959(96)03267-8. PMID:9060007.
52. Mercadante, S. 1999. Pain treatment and outcomes for patients with advanced cancer who receive follow-up care at home. Cancer, 85(8): 1849-1858. doi:10.1002/(SICI)1097-0142(19990415)85:81849::AID-CNCR273.0.CO;2-6. PMID:10223581.
53. Meuser, T., Pietruck, C., Radbruch, L., Stute, P., Lehmann, K.A., and Grond, S. 2001. Symptoms during cancer pain treatment following WHO-guidelines: a longitudinal follow-up study of symptom prevalence, severity and etiology. Pain, 93(3): 247-257. doi:10.1016/S0304-3959(01)00324-4. PMID:11514084.
54. Mundy, G.R. 2002. Metastasis to bone: causes, consequences and therapeutic opportunities. Nat. Rev. Cancer, 2(8): 584-593. doi:10.1038/nrc867. PMID: 12154351.
55. Murphy, T.H., Miyamoto, M., Sastre, A., Schnaar, R.L., and Coyle, J.T. 1989. Glutamate toxicity in a neuronal cell line involves inhibition of cystine transport leading to oxidative stress. Neuron, 2(6): 1547-1558. doi:10.1016/08966273(89)90043-3. PMID:2576375.
56. Nagae, M., Hiraga, T., Wakabayashi, H., Wang, L., Iwata, K., and Yoneda, T. 2006. Osteoclasts play a part in pain due to the inflammation adjacent to bone. Bone, 39(5): 1107-1115. doi:10.1016/j.bone.2006.04.033. PMID:16769263.
57. Narang, V.S., Pauletti, G.M., Gout, P.W., Buckley, D.J., and Buckley, A.R. 2003. Suppression of cystine uptake by sulfasalazine inhibits proliferation of human mammary carcinoma cells. Anticancer Res. 23(6C): 4571-4579. PMID: 14981898.
58. Omote, K., Kawamata, T., Kawamata, M., and Namiki, A. 1998. Formalin-induced release of excitatory amino acids in the skin of the rat hindpaw. Brain Res. 787(1): 161-164. doi:10.1016/S0006-8993(97)01568-0. PMID:9518591.
59. Orr, F.W., Lee, J., Duivenvoorden, W.C., and Singh, G. 2000. Pathophysiologic interactions in skeletal metastasis. Cancer, 88(12 Suppl.): 2912-2918. doi:10.1002/ 1097-0142(20000615)88:122912::AID-CNCR3.0.CO;2-8. PMID:10898334.
60. Ottaviano, F.G., Handy, D.E., and Loscalzo, J. 2008. Redox regulation in the extracellular environment. Circ. J. 72(1): 1-16. doi:10.1253/circj.72.1. PMID: 18159092.
61. Pampliega, O., Domercq, M., Soria, F.N., Villoslada, P., Rodriguez-Antiguedad, A., and Matute, C. 2011. Increased expression of cystine/glutamate antiporter in multiple sclerosis. J. Neuroinflammation, 8: 63. doi:10.1186/1742-2094-8-63. PMID:21639880.
62. Pargeon, K.L., and Hailey, B.J. 1999. Barriers to effective cancer pain management: a review of the literature. J. Pain Symptom Manage. 18(5): 358-368. doi:10.1016/S0885-3924(99)00097-4. PMID:10584460.
63. Patel, S.A., Warren, B.A., Rhoderick, J.F., and Bridges, R.J. 2004. Differentiation of substrate and non-substrate inhibitors of transport system xc(-): an obligate exchanger of L-glutamate and L-cystine. Neuropharmacology, 46(2): 273-284. doi:10.1016/j.neuropharm.2003.08.006. PMID:14680765.
64. Patel, S.A., Rajale, T., O'Brien, E., Burkhart, D.J., Nelson, J.K., Twamley, B., et al. 2010. Isoxazole analogues bind the system xctransporter: structure-activity relationship and pharmacophore model. Bioorg. Med. Chem. 18(1): 202-213. doi:10.1016/j.bmc.2009.11.001. PMID:19932968.
65. Reichel, A., Begley, D.J., and Abbott, N.J. 2000. Carrier-mediated delivery of metabotrophic glutamate receptor ligands to the central nervous system: structural tolerance and potential of the L-system amino acid transporter at the blood-brain barrier. J. Cereb. Blood Flow Metab. 20(1): 168-174. doi:10. 1097/00004647-200001000-00021. PMID:10616805.
66. Robe, P.A., Bentires-Alj, M., Bonif, M., Rogister, B., Deprez, M., Haddada, H., et al. 2004. In vitro and in vivo activity of the nuclear factor-kappaB inhibitor sulfasalazine in human glioblastomas. Clin. Cancer Res. 10(16): 5595-5603. doi:10.1158/1078-0432.CCR-03-0392. PMID:15328202.
67. Rosendal, L., Larsson, B., Kristiansen, J., Peolsson, M., Sogaard, K., Kjaer, M., et al. 2004. Increase in muscle nociceptive substances and anaerobic metabolism in patients with trapezius myalgia: microdialysis in rest and during exercise. Pain, 112(3): 324-334. doi:10.1016/j.pain.2004.09.017. PMID:15561388.
68. Roudier, M.P., Vesselle, H., True, L.D., Higano, C.S., Ott, S.M., King, S.H., et al. 2003. Bone histology at autopsy and matched bone scintigraphy findings in patients with hormone refractory prostate cancer: the effect of bisphosphonate therapy on bone scintigraphy results. Clin. Exp. Metastasis, 20(2), 171-180. doi:10.1023/A:1022627421000. PMID:12705638.
69. Rzeski, W., Turski, L., and Ikonomidou, C. 2001. Glutamate antagonists limit tumor growth. Proc. Natl. Acad. Sci. U.S.A. 98(11): 6372-6377. doi:10.1073/pnas. 091113598. PMID:11331750.
70. Sabino, M.A., and Mantyh, P.W. 2005. Pathophysiology of bone cancer pain. J. Support. Oncol. 3(1): 15-24. PMID:15724942.
71. Seidlitz, E.P., Sharma, M.K., Saikali, Z., Ghert, M., and Singh, G. 2009 Cancer cell lines release glutamate into the extracellular environment. Clin. Exp. Metastasis, 26: 781-787.
72. Seidlitz, E.P., Sharma, M.K., and Singh, G. 2010a. A by-product of glutathione production in cancer cells may cause disruption in bone metabolic processes. Can. J. Physiol. Pharmacol. 88: 197-203.
73. Seidlitz, E.P., Sharma, M.K., and Singh, G. 2010b. Extracellular glutamate alters mature osteoclast and osteoblast functions. Can. J. Physiol. Pharmacol. 88(9): 929-936. doi:10.1139/Y10-070. PMID:20921979.
74. Sharma, M.K., Seidlitz, E.P., and Singh, G. 2010. Cancer cells release glutamate via the cystine/glutamate antiporter. Biochem. Biophys. Res. Commun. 391(1): 91-95. doi:10.1016/j.bbrc.2009.10.168. PMID:19896463.
75. Shukla, K., Thomas, A.G., Ferraris, D.V., Hin, N., Sattler, R., Alt, J., et al. 2011. Inhibition of xc transporter-mediated cystine uptake by sulfasalazine analogs. Bioorg. Med. Chem. Lett. 21(20): 6184-6187. doi:10.1016/j.bmcl.2011.07. 081. PMID:21889337.
76. Skerry, T.M. 2008. The role of glutamate in the regulation of bone mass and architecture. J. Musculoskelet. Neuronal Interact. 8: 166-173.
77. Solomayer, E.F., Diel, I.J., Meyberg, G.C., Gollan, C., and Bastert, G. 2000. Metastatic breast cancer: clinical course, prognosis and therapy related to the first site of metastasis. Breast Cancer Res. Treat. 59(3): 271-278. doi:10.1023/A: 1006308619659. PMID:10832597.
78. Takada, A., and Bannai, S. 1984. Transport of cystine in isolated rat hepatocytes in primary culture. J. Biol. Chem. 259(4): 2441-2445. PMID:6142043.
79. Takano, T., Lin, J.H., Arcuino, G., Gao, Q., Yang, J., and Nedergaard, M. 2001. Glutamate release promotes growth of malignant gliomas. Nat. Med. 7(9): 1010-1015. doi:10.1038/nm0901-1010. PMID:11533703.
80. Takarada-Iemata, M., Takarada, T., Nakamura, Y., Nakatani, E., Hori, O., and Yoneda, Y. 2011. Glutamate preferentially suppresses osteoblastogenesis than adipogenesis through the cystine/glutamate antiporter in mesenchymal stem cells. J. Cell. Physiol. 226: 652-665. doi:10.1002/jcp.22390. PMID: 20717926.
81. Thomas, R.J., Guise, T.A., Yin, J.J., Elliott, J., Horwood, N.J., Martin, T. J. et al. 1999. Breast cancer cells interact with osteoblasts to support osteoclast formation. Endocrinology, 140: 4451-4458. doi:10.1210/en.140.10.4451. PMID: 10499498.
82. Verrey, F., Closs, E.I., Wagner, C.A., Palacin, M., Endou, H., and Kanai, Y. 2004. CATs and HATs: the SLC7 family of amino acid transporters. Pflugers Arch. 447(5): 532-542. doi:10.1007/s00424-003-1086-z. PMID:14770310.
83. Wahl, C., Liptay, S., Adler, G., and Schmid, R.M. 1998. Sulfasalazine: a potent and specific inhibitor of nuclear factor kappa B. J. Clin. Invest. 101(5): 1163-1174. doi:10.1172/JCI992. PMID:9486988.
84. Wang, H., Tamba, M., Kimata, M., Sakamoto, K., Bannai, S., and Sato, H. 2003. Expression of the activity of cystine/glutamate exchange transporter, system x(c)(-), by xCT and rBAT. Biochem. Biophys. Res. Commun. 305(3): 611-618. doi:10.1016/S0006-291X(03)00808-8. PMID:12763038.
85. Warburg, O., Wind, F., and Negelein, E. 1927. The metabolism of tumors in the body. J. Gen. Physiol. 8(6): 519-530. doi:10.1085/jgp.8.6.519. PMID:19872213.
86. Watanabe, H., and Bannai, S. 1987. Induction of cystine transport activity in mouse peritoneal macrophages. J. Exp. Med. 165(3): 628-640. doi:10.1084/jem. 165.3.628. PMID:2880923.
87. WHO. 1996. Cancer Pain Relief, 2nd ed. Geneva: World Health Organization.
88. Wolfe, M.M., Lichtenstein, D.R., and Singh, G. 1999. Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs. N. Engl. J. Med. 340(24): 1888-1899. doi:10.1056/NEJM199906173402407. PMID:10369853.
89. Wu, G., Fang, Y.Z., Yang, S., Lupton, J.R., and Turner, N.D. 2004. Glutathione metabolism and its implications for health. J. Nutr. 134(3): 489-492. PMID: 14988435.
90. Yavas, O., Hayran, M., and Ozisik, Y. 2007. Factors affecting survival in breast cancer patients following bone metastasis. Tumori, 93(6): 580-586. PMID: 18338493.
91. Ye, Z.C., and Sontheimer, H. 1999. Glioma cells release excitotoxic concentrations of glutamate. Cancer Res. 59(17): 4383-4391. PMID:10485487.
92. Ye, Z.C., Rothstein, J.D., and Sontheimer, H. 1999. Compromised glutamate transport in human glioma cells: reduction-mislocalization of sodium-dependent glutamate transporters and enhanced activity of cystineglutamate exchange. J. Neurosci. 19(24): 10767-10777. PMID:10594060.
93. Yoneda, T., Hata, K., Nakanishi, M., Nagae, M., Nagayama, T., Wakabayashi, H., et al. 2011. Involvement of acidic microenvironment in the pathophysiology of cancer-associated bone pain. Bone, 48(1): 100-105. doi:10.1016/j.bone.2010. 07.009. PMID:20637323.
94. Zech, D.F., Grond, S., Lynch, J., Hertel, D., and Lehmann, K.A. 1995. Validation of World Health Organization Guidelines for cancer pain relief: a 10-year prospective study. Pain, 63(1): 65-76. doi:10.1016/0304-3959(95)00017-M. PMID: 8577492.
95. Zhu, M., and Bowden, G.T. 2004. Molecular mechanism(s) for UV-B irradiation-induced glutathione depletion in cultured human keratinocytes. Photochem. Photobiol. 80(2): 191-196. doi:10.1562/2004-02-26-RA-091.1. PMID: 15244506.